Business News | Stock and Share Market News

























A ready reckoner that seeks to explain why Bharat Biotech sells its COVID-19 vaccine sells its vaccine in the market at double the price of its competitor Covishield manufactured by Serum Institute.


Why Bharat Biotech's Covaxin remains expensive in private markets?




Name Price Change % Chg
Indiabulls Hsg 298.50 11.15 3.88
Sbi 430.35 0.75 0.17
Ntpc 118.20 -0.60 -0.51
Nhpc 26.85 0.00 0

Forum

Forum

YOUR OPINION

https://www.moneycontrol.com/

COMMENTS

Thank You for Voting